Thiostrepton suppresses rhabdomyosarcoma progression by targeting the PI3K–AKT pathway Post author:admin Post published:October 30, 2025 Post category:uncategorized Rhabdomyosarcoma (RMS) accounts for up to 10% of childhood cancers and nearly half of pediatric soft tissue sarcomas. You Might Also Like Low-cost diagnostic tool delivers COVID-19 test results in under an hour July 22, 2025 Can scientists predict life longevity from a drop of blood? June 8, 2025 Temporary heart pump before PCI shows no significant benefit March 29, 2026